Search results
Results from the WOW.Com Content Network
NHS staff must be able to blow the whistle and the health service must listen and act, Health Secretary Victoria Atkins has said. ... than 100,000 cases and more than eight in 10 staff who spoke ...
NHS Whistleblowers, a support group made up of current and former doctors, midwives and nurses, said workers should able to give evidence regarding an NHS “culture detrimental to patient safety”.
Legal claims against the pharmaceutical industry have varied widely over the past two decades, including Medicare and Medicaid fraud, off-label promotion, and inadequate manufacturing practices. [ 3 ] [ 4 ] With respect to off-label promotion, specifically, a federal court recognized off-label promotion as a violation of the False Claims Act ...
The case had widespread effects including establishing a new standard for pharmaceutical marketing practices; broadening the use of the False Claims Act to make fraudulent marketing claims criminal violations; exposing complicity and active participation in fraud by renowned physicians; and demonstrating how medical literature had been ...
In 1996, whistleblower David Franklin left his position as a medical liaison with Parke-Davis, a pharmaceutical division of Warner-Lambert Company, after learning of the company's marketing strategy to promote the epilepsy drug Neurontin for uses not approved by the FDA. [1] Franklin and his attorney, Thomas M. Greene, filed a lawsuit, Franklin v.
The world needs whistleblowers, perhaps now more than ever. But whistleblowing has never been more dangerous. Jennifer Gibson has seen this problem develop up close. As a whistleblower lawyer ...
Claims under the law have typically involved government health care programs (Medicare, Medicaid and TriCare), military, or other government spending programs. FCA actions dominate the list of largest pharmaceutical settlements. Between 1987 and 2019, the government recovered more than $62 billion under the False Claims Act. [5]
“The daily assault on complainant’s mental and physical health ultimately required him to withdraw from his contract with Perdue on January 26, 2016,” the whistleblower complaint says ...